Unit
Division of Infectious Diseases, Infection Prevention and Travel Medicine
INFEKT · Dept. I
Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir
Young J, Bucher H, Battegay M, Weber R, Cavassini M, Calmy A, Vernazza P, Bernasconi E, Furrer H, Fux C, Schäfer J, the Swiss HIV Cohort Study. Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir. AIDS 2012; 26:567-575.
Mar 13, 2012Renal function in patients with HIV starting therapy with tenofovir and either efavirenz, lopinavir or atazanavir
Mar 13, 2012AIDS 2012; 26:567-575
Young Jim, Bucher Heiner C, Battegay Manuel, Weber Rainer, Cavassini Matthias, Calmy Alexandra, Vernazza Pietro, Bernasconi Enos, Furrer Hansjakob, Fux Christoph A, Schäfer Juliane, the Swiss HIV Cohort Study
Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo
Pillai S, Wong J, Günthard H, Ledergerber B, Bernasconi E, Bregenzer A, Hirschel B, Battegay M, Fellay J, Rauch A, Kovari H, Greene W, Yukl S, Fujimoto K, Monto A, Skasko M, Guatelli J, Abdel-Mohsen M, Swiss HIV Cohort Study. Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo. Proc Natl Acad Sci USA 2012; 109:3035-40.
Feb 6, 2012Role of retroviral restriction factors in the interferon-α-mediated suppression of HIV-1 in vivo
Feb 6, 2012Proc Natl Acad Sci USA 2012; 109:3035-40
Pillai Satish K, Wong Joseph K, Günthard Huldrych F, Ledergerber Bruno, Bernasconi Enos, Bregenzer Andrea, Hirschel Bernard, Battegay Manuel, Fellay Jacques, Rauch Andri, Kovari Helen, Greene Warner C, Yukl Steven, Fujimoto Katsuya, Monto Alexander, Skasko Mark, Guatelli John, Abdel-Mohsen Mohamed, Swiss HIV Cohort Study
Outcomes of antiretroviral therapy in the Swiss HIV Cohort Study: latent class analysis
Keiser O, Egger M, Ledergerber B, Nicca D, Glass T, Cavassini M, Calmy A, Rauch A, Spycher B, Swiss HIV Cohort Study. Outcomes of antiretroviral therapy in the Swiss HIV Cohort Study: latent class analysis. AIDS Behav 2012; 16:245-55.
Feb 1, 2012Outcomes of antiretroviral therapy in the Swiss HIV Cohort Study: latent class analysis
Feb 1, 2012AIDS Behav 2012; 16:245-55
Keiser Olivia, Egger Matthias, Ledergerber Bruno, Nicca Dunja, Glass Tracy R, Cavassini Matthias, Calmy Alexandra, Rauch Andri, Spycher Ben, Swiss HIV Cohort Study
Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians
Huber M, Weber R, Held L, Jaccard R, Bernasconi E, Nicca D, Orasch C, Calmy A, Battegay M, Cusini A, Fehr J, Young J, Sauter R, Ledergerber B, Swiss HIV Cohort Study Group. Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians. HIV Med 2012; 13:387-97.
Jan 18, 2012Outcome of smoking cessation counselling of HIV-positive persons by HIV care physicians
Jan 18, 2012HIV Med 2012; 13:387-97
Huber M, Weber R, Held L, Jaccard R, Bernasconi E, Nicca Dunja, Orasch C, Calmy A, Battegay M, Cusini A, Fehr J, Young J, Sauter R, Ledergerber B, Swiss HIV Cohort Study Group
Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection
Clifford G, Schöni-Affolter F, Keiser O, Calmy A, Cavassini M, Bernasconi E, Battegay M, Schmid P, Fehr J, Wandeler G, Jundt G, Ess S, Levi F, Korol D, Bouchardy C, Egger M, Franceschi S, Lise M, Swiss HIV Cohort Study. Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection. Br J Cancer 2012; 106:447-52.
Jan 12, 2012Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection
Jan 12, 2012Br J Cancer 2012; 106:447-52
Clifford G M, Schöni-Affolter F, Keiser O, Calmy A, Cavassini M, Bernasconi E, Battegay M, Schmid Patrick, Fehr J, Wandeler G, Jundt G, Ess S, Levi F, Korol D, Bouchardy C, Egger M, Franceschi S, Lise M, Swiss HIV Cohort Study
Determinants of Sustained Viral Suppression in HIV-Infected Patients with Self-Reported Poor Adherence to Antiretroviral Therapy
Glass T, Marzolini C, Battegay M, Wandeler G, Bernasconi E, Hirschel B, Nicca D, Rickenbach M, Günthard H, Bucher H, Csajka C, Decosterd L, Telenti A, Rotger M, the Swiss HIV Cohort Study. Determinants of Sustained Viral Suppression in HIV-Infected Patients with Self-Reported Poor Adherence to Antiretroviral Therapy. PloS one 2012; 7:e29186.
Jan 3, 2012Determinants of Sustained Viral Suppression in HIV-Infected Patients with Self-Reported Poor Adherence to Antiretroviral Therapy
Jan 3, 2012PloS one 2012; 7:e29186
Glass Tracy R, Marzolini Catia, Battegay Manuel, Wandeler Gilles, Bernasconi Enos, Hirschel Bernard, Nicca Dunja, Rickenbach Martin, Günthard Huldrych F, Bucher Heiner C, Csajka Chantal, Decosterd Laurent, Telenti Amalio, Rotger Margalida, the Swiss HIV Cohort Study
Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study
Staehelin C, Furrer H, Bernasconi E, Schmid P, Cavassini M, Elzi L, Weber R, Calmy A, Keiser O, Swiss HIV Cohort Study. Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study. J Acquir Immune Defic Syndr 2012; 59:79-85.
Jan 1, 2012Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study
Jan 1, 2012J Acquir Immune Defic Syndr 2012; 59:79-85
Staehelin Cornelia, Furrer Hansjakob, Bernasconi Enos, Schmid Patrick, Cavassini Matthias, Elzi Luigia, Weber Rainer, Calmy Alexandra, Keiser Olivia, Swiss HIV Cohort Study
A comparison of initial antiretroviral therapy in the Swiss HIV Cohort Study and the recommendations of the International AIDS Society-USA
Wandeler G, Furrer H, Vernazza P, Clerc O, Battegay M, Bernasconi E, Günthard H, Hirschel B, Keiser O, Swiss HIV Cohort Study. A comparison of initial antiretroviral therapy in the Swiss HIV Cohort Study and the recommendations of the International AIDS Society-USA. PloS one 2011; 6:e27903.
Dec 20, 2011A comparison of initial antiretroviral therapy in the Swiss HIV Cohort Study and the recommendations of the International AIDS Society-USA
Dec 20, 2011PloS one 2011; 6:e27903
Wandeler Gilles, Furrer Hansjakob, Vernazza Pietro, Clerc Olivier, Battegay Manuel, Bernasconi Enos, Günthard Huldrych F, Hirschel Bernard, Keiser Olivia, Swiss HIV Cohort Study
Impact of a nurse vaccination program on hepatitis B immunity in a Swiss HIV clinic
Boillat Blanco N, Cavassini M, Bertisch B, Weber R, Rauch A, Elzi L, Calmy A, Bernasconi E, Giulieri S, Da Costa V, Probst A, Bochud P. Impact of a nurse vaccination program on hepatitis B immunity in a Swiss HIV clinic. J Acquir Immune Defic Syndr 2011; 58:472-4.
Dec 15, 2011Impact of a nurse vaccination program on hepatitis B immunity in a Swiss HIV clinic
Dec 15, 2011J Acquir Immune Defic Syndr 2011; 58:472-4
Boillat Blanco Noémie, Cavassini Matthias, Bertisch Barbara, Weber Rainer, Rauch Andri, Elzi Luigia, Calmy Alexandra, Bernasconi Enos, Giulieri Stefano, Da Costa Vreneli Waelti, Probst Arnold, Bochud Pierre-Yves
Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study
Thierfelder C, Ledergerber B, Gutmann C, Bernasconi E, Calmy A, Cavassini M, Furrer H, Elzi L, Weber R, Swiss HIV Cohort Study Group. Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study. HIV Med 2011; 13:118-26.
Nov 22, 2011Participation, characteristics and retention rates of HIV-positive immigrants in the Swiss HIV Cohort Study
Nov 22, 2011HIV Med 2011; 13:118-26
Thierfelder C, Ledergerber B, Gutmann Christine, Bernasconi E, Calmy A, Cavassini M, Furrer H, Elzi L, Weber R, Swiss HIV Cohort Study Group
Early Antiretroviral Therapy During Primary HIV-1 Infection Results in a Transient Reduction of the Viral Setpoint upon Treatment Interruption
von Wyl V, Günthard H, Joos B, Weber R, Vernazza P, Hirschel B, Rauch A, Cavassini M, Bernasconi E, Battegay M, Kuster H, Niederoest B, Fischer M, Gianella S, the Swiss HIV Cohort Study (SHCS). Early Antiretroviral Therapy During Primary HIV-1 Infection Results in a Transient Reduction of the Viral Setpoint upon Treatment Interruption. PloS one 2011; 6:e27463.
Nov 15, 2011Early Antiretroviral Therapy During Primary HIV-1 Infection Results in a Transient Reduction of the Viral Setpoint upon Treatment Interruption
Nov 15, 2011PloS one 2011; 6:e27463
von Wyl Viktor, Günthard Huldrych F, Joos Beda, Weber Rainer, Vernazza Pietro, Hirschel Bernard, Rauch Andri, Cavassini Matthias, Bernasconi Enos, Battegay Manuel, Kuster Herbert, Niederoest Barbara, Fischer Marek, Gianella Sara, the Swiss HIV Cohort Study (SHCS)
Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-Infection
Elzi L, Bassetti S, Bernasconi E, Hoffmann M, Hirschel B, Cavassini M, Fehr J, Furrer H, Steffen I, Battegay M. Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-Infection. BMC Infect Dis 2011; 11:319.
Nov 15, 2011Improved sensitivity of an interferon-gamma release assay (T-SPOT.TB) in combination with tuberculin skin test for the diagnosis of latent tuberculosis in the presence of HIV co-Infection
Nov 15, 2011BMC Infect Dis 2011; 11:319
Elzi Luigia, Bassetti Stefano, Bernasconi Enos, Hoffmann Matthias, Hirschel Bernard, Cavassini Matthias, Fehr Jan, Furrer Hansjakob, Steffen Ingrid, Battegay Manuel
Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations
von Wyl V, Günthard H, Ledergerber B, Vernazza P, Hirschel B, Furrer H, Cavassini M, Bernasconi E, Battegay M, Klimkait T, Cellerai C, Shah C, Böni J, Yerly S, Swiss HIV Cohort Study. Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations. Clin Infect Dis 2011; 54:131-40.
Nov 4, 2011Incidence of HIV-1 drug resistance among antiretroviral treatment-naive individuals starting modern therapy combinations
Nov 4, 2011Clin Infect Dis 2011; 54:131-40
von Wyl Viktor, Günthard Huldrych F, Ledergerber Bruno, Vernazza Pietro, Hirschel Bernard, Furrer Hansjakob, Cavassini Matthias, Bernasconi Enos, Battegay Manuel, Klimkait Thomas, Cellerai Cristina, Shah Cyril, Böni Jürg, Yerly Sabine, Swiss HIV Cohort Study
Preexposure prophylaxis and timed intercourse for HIV-discordant couples willing to conceive a child
Vernazza P, Graf I, Sonnenberg-Schwan U, Geit M, Meurer A. Preexposure prophylaxis and timed intercourse for HIV-discordant couples willing to conceive a child. AIDS 2011; 25:2005-8.
Oct 23, 2011Preexposure prophylaxis and timed intercourse for HIV-discordant couples willing to conceive a child
Oct 23, 2011AIDS 2011; 25:2005-8
Vernazza Pietro, Graf Irma, Sonnenberg-Schwan Ulrike, Geit Maria, Meurer Anja
Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B
Scherrer A, Günthard H, Held L, Bernasconi E, Vernazza P, Elzi L, Cavassini M, Hirschel B, Rauch A, Bürgisser P, Klimkait T, Yerly S, Böni J, von Wyl V, Ledergerber B, Swiss HIV Cohort Study. Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B. Clin Infect Dis 2011; 53:1143-52.
Oct 13, 2011Improved virological outcome in White patients infected with HIV-1 non-B subtypes compared to subtype B
Oct 13, 2011Clin Infect Dis 2011; 53:1143-52
Scherrer Alexandra U, Günthard Huldrych F, Held Leonhard, Bernasconi Enos, Vernazza Pietro, Elzi Luigia, Cavassini Matthias, Hirschel Bernard, Rauch Andri, Bürgisser Philippe, Klimkait Thomas, Yerly Sabine, Böni Jürg, von Wyl Viktor, Ledergerber Bruno, Swiss HIV Cohort Study
Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study
Hasse B, Weber R, Bernasconi E, Bertisch B, Cavassini M, Hirschel B, Battegay M, Furrer H, Ledergerber B, Swiss HIV Cohort Study. Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study. Clin Infect Dis 2011; 53:1130-9.
Oct 13, 2011Morbidity and aging in HIV-infected persons: the Swiss HIV cohort study
Oct 13, 2011Clin Infect Dis 2011; 53:1130-9
Hasse Barbara, Weber Rainer, Bernasconi Enos, Bertisch Barbara, Cavassini Matthias, Hirschel Bernhard, Battegay Manuel, Furrer Hansjakob, Ledergerber Bruno, Swiss HIV Cohort Study
Wenn Scarlet erwachsen wird – Scharlach ohne Streptokokken
Brunner F, Boggian K, Diethelm M. Wenn Scarlet erwachsen wird – Scharlach ohne Streptokokken. Schweiz Med Forum 2011; 11:730-731.
Oct 12, 2011Wenn Scarlet erwachsen wird – Scharlach ohne Streptokokken
Oct 12, 2011Schweiz Med Forum 2011; 11:730-731
Brunner Felix, Boggian Katia, Diethelm Markus
The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland
von Wyl V, Günthard H, Bonhoeffer S, Ledergerber B, Bernasconi E, Vernazza P, Battegay M, Staehelin C, Cavassini M, Hirschel B, Weber R, Klimkait T, Bürgisser P, Shah C, Böni J, Yerly S, Kouyos R, Swiss HIV Cohort Study. The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland. J Infect Dis 2011; 204:1095-103.
Oct 1, 2011The role of migration and domestic transmission in the spread of HIV-1 non-B subtypes in Switzerland
Oct 1, 2011J Infect Dis 2011; 204:1095-103
von Wyl Viktor, Günthard Huldrych F, Bonhoeffer Sebastian, Ledergerber Bruno, Bernasconi Enos, Vernazza Pietro, Battegay Manuel, Staehelin Cornelia, Cavassini Matthias, Hirschel Bernard, Weber Rainer, Klimkait Thomas, Bürgisser Philippe, Shah Cyril, Böni Jürg, Yerly Sabine, Kouyos Roger D, Swiss HIV Cohort Study
A comment on Marschall et Al
Babouee Flury B, Elzi L, Frei R, Widmer A, Battegay M. A comment on Marschall et Al. Clin Infect Dis 2011; 53:748, author reply 748-9.
Oct 1, 2011A comment on Marschall et Al
Oct 1, 2011Clin Infect Dis 2011; 53:748, author reply 748-9
Babouee Flury Baharak, Elzi Luigia, Frei Reno, Widmer Andreas, Battegay Manuel
A randomized cross-over study to compare raltegravir and efavirenz (SWITCH-ER study)
Nguyen A, Schmid P, Bernasconi E, Rauch A, Elzi L, Mello A, Cavassini M, Mercier I, Delhumeau C, Calmy A, Hirschel B. A randomized cross-over study to compare raltegravir and efavirenz (SWITCH-ER study). AIDS 2011; 25:1481-7.
Jul 31, 2011A randomized cross-over study to compare raltegravir and efavirenz (SWITCH-ER study)
Jul 31, 2011AIDS 2011; 25:1481-7
Nguyen Alain, Schmid Patrick, Bernasconi Enos, Rauch Andri, Elzi Luigia, Mello Aurelie F, Cavassini Matthias, Mercier Isabelle, Delhumeau Cécile, Calmy Alexandra, Hirschel Bernard